DK2726141T3 - Enhed til oral levering af terapeutiske forbindelser - Google Patents

Enhed til oral levering af terapeutiske forbindelser Download PDF

Info

Publication number
DK2726141T3
DK2726141T3 DK12804668.7T DK12804668T DK2726141T3 DK 2726141 T3 DK2726141 T3 DK 2726141T3 DK 12804668 T DK12804668 T DK 12804668T DK 2726141 T3 DK2726141 T3 DK 2726141T3
Authority
DK
Denmark
Prior art keywords
relations
therapeutic
unit
oral delivery
oral
Prior art date
Application number
DK12804668.7T
Other languages
English (en)
Inventor
Mir Imran
Original Assignee
Rani Therapeutics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47424526&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2726141(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rani Therapeutics Llc filed Critical Rani Therapeutics Llc
Application granted granted Critical
Publication of DK2726141T3 publication Critical patent/DK2726141T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14539Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring pH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4836Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/07Endoradiosondes
    • A61B5/073Intestinal transmitters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Anesthesiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK12804668.7T 2011-06-29 2012-06-27 Enhed til oral levering af terapeutiske forbindelser DK2726141T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161571641P 2011-06-29 2011-06-29
PCT/US2012/044441 WO2013003487A1 (en) 2011-06-29 2012-06-27 Device, system and methods for the oral delivery of therapeutic compounds

Publications (1)

Publication Number Publication Date
DK2726141T3 true DK2726141T3 (da) 2020-03-02

Family

ID=47424526

Family Applications (2)

Application Number Title Priority Date Filing Date
DK12804668.7T DK2726141T3 (da) 2011-06-29 2012-06-27 Enhed til oral levering af terapeutiske forbindelser
DK19203957.6T DK3653223T3 (da) 2011-06-29 2012-06-27 Enhed til oral levering af terapeutiske forbindelser

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK19203957.6T DK3653223T3 (da) 2011-06-29 2012-06-27 Enhed til oral levering af terapeutiske forbindelser

Country Status (11)

Country Link
EP (3) EP3653223B1 (da)
JP (6) JP6101261B2 (da)
CN (1) CN103987422B (da)
AU (5) AU2012275417B9 (da)
CA (2) CA3159845A1 (da)
DK (2) DK2726141T3 (da)
ES (2) ES2898893T3 (da)
IN (1) IN2014CN00338A (da)
PL (2) PL2726141T3 (da)
PT (2) PT3653223T (da)
WO (1) WO2013003487A1 (da)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5854513B2 (ja) 2009-08-03 2016-02-09 インキューブ ラブズ, エルエルシー 腸管内でインクレチン生産を刺激するための嚥下可能カプセルおよび方法
US8759284B2 (en) 2009-12-24 2014-06-24 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9149617B2 (en) 2010-12-23 2015-10-06 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US8809269B2 (en) 2010-12-23 2014-08-19 Rani Therapeutics, Llc Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8969293B2 (en) 2010-12-23 2015-03-03 Rani Therapeutics, Llc Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8809271B2 (en) 2010-12-23 2014-08-19 Rani Therapeutics, Llc Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8764733B2 (en) 2010-12-23 2014-07-01 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9284367B2 (en) 2010-12-23 2016-03-15 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9861683B2 (en) 2010-12-23 2018-01-09 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9283179B2 (en) 2010-12-23 2016-03-15 Rani Therapeutics, Llc GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9259386B2 (en) 2010-12-23 2016-02-16 Rani Therapeutics, Llc Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9629799B2 (en) 2010-12-23 2017-04-25 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8980822B2 (en) 2010-12-23 2015-03-17 Rani Therapeutics, Llc Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9402807B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9415004B2 (en) 2010-12-23 2016-08-16 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8734429B2 (en) 2010-12-23 2014-05-27 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US10639272B2 (en) 2010-12-23 2020-05-05 Rani Therapeutics, Llc Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
US9402806B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8846040B2 (en) 2010-12-23 2014-09-30 Rani Therapeutics, Llc Therapeutic agent preparations comprising etanercept for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
CA3159845A1 (en) * 2011-06-29 2013-01-03 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
JP6796484B2 (ja) * 2013-03-15 2020-12-09 ラニ セラピューティクス, エルエルシー 治療化合物の経口送達のためのデバイス
CN104605900B (zh) * 2013-11-04 2017-04-12 上海交通大学医学院附属第九人民医院 一种可同时提供生物附加效应的皮肤扩张器
US10689460B2 (en) 2014-05-15 2020-06-23 Incube Labs, Llc PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US11548940B2 (en) 2014-05-15 2023-01-10 Rani Therapeutics, Llc Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
CN104287685B (zh) * 2014-10-08 2016-03-02 南京航空航天大学 弹性杆导向式胶囊内镜机器人驻停及位姿调整装置与方法
WO2016179120A1 (en) * 2015-05-01 2016-11-10 Mir Imran Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins
CA2984422C (en) * 2015-05-08 2023-10-17 Incube Labs, Llc Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
CN108401419A (zh) * 2015-09-08 2018-08-14 因库博实验室有限责任公司 使用可吞服药物递送装置递送到肠道内腔中的pcsk9抗体制剂
US10190894B2 (en) * 2015-12-26 2019-01-29 Intel Corporation Technologies for controlling degradation of sensing circuits
CN105476593B (zh) * 2015-12-30 2019-02-05 中科院合肥技术创新工程院 一种用于检查食管疾病的胶囊内窥镜
JP7097816B2 (ja) * 2016-03-09 2022-07-08 インキューブ ラブズ, エルエルシー 中実組織中に生存細胞を送達するための方法および物品
JP7295811B2 (ja) * 2017-05-17 2023-06-21 マサチューセッツ インスティテュート オブ テクノロジー 自己作動物品
AU2018387769B2 (en) * 2017-12-18 2024-05-23 Biograil ApS Oral delivery of active drug substances
WO2019135213A1 (en) * 2018-01-03 2019-07-11 Weiss Menachem Peter In-vivo insertable devices having fail-safe evacuation
US10675248B2 (en) 2018-08-14 2020-06-09 Alma Therapeutics Ltd. Expandable pill
KR102047610B1 (ko) * 2018-12-18 2019-11-22 이민우 다수의 소형 주사기 또는 주사부를 갖는 마이크로 니들 장치
KR20210142660A (ko) * 2019-03-14 2021-11-25 이소캡 아게 점막에 적용하기 위한 약제학적 제형 및 이의 생산 방법
EP4037753A4 (en) * 2019-10-01 2024-01-03 Rani Therapeutics, LLC SELF-SIZING DEVICE FOR DELIVERING A FORMULATION TO THE WALL OF A LIGHT
CN115300774B (zh) * 2022-08-27 2024-01-30 深圳市资福医疗技术有限公司 一种药剂递送装置、释药方法及应用其的释药胶囊

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60129057A (ja) * 1983-12-14 1985-07-10 住友化学工業株式会社 針状固形製剤投与針
DK42093D0 (da) * 1993-04-07 1993-04-07 Bukh Meditec Administrationsmetode
US6638246B1 (en) * 2000-11-28 2003-10-28 Scimed Life Systems, Inc. Medical device for delivery of a biologically active material to a lumen
EP1587407B1 (en) * 2002-12-26 2012-03-07 Given Imaging Ltd. Immobilizable in vivo sensing device
US20050058701A1 (en) * 2003-01-29 2005-03-17 Yossi Gross Active drug delivery in the gastrointestinal tract
WO2004066903A2 (en) * 2003-01-29 2004-08-12 E-Pill Pharma Ltd. Active drug delivery in the gastrointestinal tract
US20050038415A1 (en) * 2003-08-06 2005-02-17 Rohr William L. Method and apparatus for the treatment of obesity
JP4526253B2 (ja) * 2003-10-01 2010-08-18 オリンパス株式会社 体内観察装置
DE102004026615A1 (de) * 2004-06-01 2005-12-29 Siemens Ag Vorrichtung und Verfahren zur Freisetzung eines in das Körperinnere eines Patienten geführten therapeutischen Mittels
JP2008522778A (ja) * 2004-12-14 2008-07-03 イー−ピル ファーマ リミティド 電気透過性増加を用いた薬物又は物質の局所輸送
US20090306633A1 (en) 2005-01-18 2009-12-10 Koninklijke Philips Electronics, N.V. Electronically controlled capsule
US7785291B2 (en) * 2005-03-01 2010-08-31 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
DE102005032369A1 (de) 2005-07-08 2007-01-11 Siemens Ag Endoskopiekapsel
JP4402648B2 (ja) * 2005-12-16 2010-01-20 オリンパス株式会社 被検体内導入装置
AU2007254213B2 (en) * 2006-05-18 2013-01-17 Tulip Medical Ltd. Bioerodible self-deployable intragastric and non-gastric implants
US20070288033A1 (en) * 2006-06-09 2007-12-13 Allergan, Inc. Intragastric balloon retrieval mechanisms
WO2010045477A2 (en) * 2008-10-16 2010-04-22 Obalon Therapeutics, Inc. Intragastric volume-occupying device and method for fabricating same
WO2010093834A2 (en) * 2009-02-12 2010-08-19 Incube Labs, Llc Skin penetrating device and method for subcutaneous solid drug delivery
JP2010273936A (ja) * 2009-05-29 2010-12-09 Tti Ellebeau Inc バルーンカテーテル
US8759284B2 (en) * 2009-12-24 2014-06-24 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
EP3756657A1 (en) * 2009-12-24 2020-12-30 Rani Therapeutics, LLC Swallowable drug delivery device
CA3159845A1 (en) * 2011-06-29 2013-01-03 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds

Also Published As

Publication number Publication date
JP2017113601A (ja) 2017-06-29
AU2017206226A1 (en) 2017-08-03
CN103987422A (zh) 2014-08-13
IN2014CN00338A (da) 2015-04-03
JP2024074923A (ja) 2024-05-31
AU2020200413A1 (en) 2020-02-13
EP2726141A4 (en) 2015-05-06
AU2012275417A1 (en) 2014-01-23
WO2013003487A1 (en) 2013-01-03
EP2726141B1 (en) 2019-12-25
JP2020171801A (ja) 2020-10-22
DK3653223T3 (da) 2021-11-15
AU2012275417B9 (en) 2017-08-31
PT2726141T (pt) 2020-02-24
AU2020200413B2 (en) 2020-10-08
JP6101261B2 (ja) 2017-03-22
JP6742383B2 (ja) 2020-08-19
CN103987422B (zh) 2017-02-15
AU2012275417B2 (en) 2017-04-20
EP2726141A1 (en) 2014-05-07
PL3653223T3 (pl) 2021-12-20
JP2022044726A (ja) 2022-03-17
EP3973983A1 (en) 2022-03-30
CA2840487C (en) 2022-09-27
PT3653223T (pt) 2021-12-06
JP2019055197A (ja) 2019-04-11
JP7016387B2 (ja) 2022-02-04
EP3653223B1 (en) 2021-08-25
ES2765029T3 (es) 2020-06-05
EP3653223A1 (en) 2020-05-20
ES2898893T3 (es) 2022-03-09
AU2023202150A1 (en) 2023-05-04
AU2017206226B2 (en) 2019-10-24
AU2020294353B2 (en) 2023-01-12
AU2020294353A1 (en) 2021-02-25
JP2014520600A (ja) 2014-08-25
PL2726141T3 (pl) 2020-06-15
CA2840487A1 (en) 2013-01-03
CA3159845A1 (en) 2013-01-03

Similar Documents

Publication Publication Date Title
DK2726141T3 (da) Enhed til oral levering af terapeutiske forbindelser
DK2968071T3 (da) Enhed til oral levering af terapeutiske forbindelser
DK3461478T3 (da) Synkbar enhed til levering af lægemidler
CO6852076A2 (es) Composiciones farmacéuticas inhalables
DK2768479T3 (da) Hjælpestoffer til nikotin-indeholdende terapeutiske sammensætninger
DK3520805T3 (da) Sammensætninger til behandling af myelofibrose
DK3527241T3 (da) Indretning til administration af lægemiddel
DK2694038T3 (da) Farmaceutisk sammensætning
BR112014003052A2 (pt) composições farmacêuticas
DK2701733T3 (da) Forbindelser til behandling af neuropsykiatriske forstyrrelser
DK2706982T4 (da) Intranasale farmaceutiske dosisformer omfattende naloxon
DK2701773T3 (da) Dosisstyredele til injektionssprøjte
DK2688557T3 (da) Fremgangsmåder og sammensætninger til behandling af forstyrelse af opmærksomhed
CO6930367A2 (es) Composiciones farmaceúticas
DK3603704T3 (da) Indgivelse af medikament
DK2773648T3 (da) Farmaceutiske forbindelser til anvendelse i behandlingen af clostridium difficile-infektion
CO6950486A2 (es) Solución para administración oral
DK2685898T3 (da) Beregning af en medikamentdosis
BR112014014536A2 (pt) um inalador compreendendo uma composição contendo tiotrópio
SMT201600465B (it) Dispositivo di inalazione
CO6940426A2 (es) Formulaciones farmacéuticas
DK3542851T3 (da) Implanterbare indretninger til levering af bioaktive midler
BR112014009319A2 (pt) compostos farmacêuticos
BR112014012043A2 (pt) emplastro
CO6880064A2 (es) Métodos terapéuticos